{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:56:46Z","timestamp":1792814206141,"version":"4.5.0"},"reference-count":158,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["QML20230106"],"award-info":[{"award-number":["QML20230106"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024ZD0520302"],"award-info":[{"award-number":["2024ZD0520302"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC0110904"],"award-info":[{"award-number":["2017YFC0110904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101923"],"award-info":[{"award-number":["82101923"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.gendis.2025.101742","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:15:31Z","timestamp":1751022931000},"page":"101742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["High-dose vitamin C: A promising anti-tumor agent, insight from mechanisms, clinical research, and challenges"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8960-6995","authenticated-orcid":false,"given":"Hanzheng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gendis.2025.101742_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41568-019-0135-7","article-title":"Targeting cancer vulnerabilities with high-dose vitamin C","volume":"19","author":"Ngo","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.gendis.2025.101742_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2891-2-7","article-title":"Vitamin C in human health and disease is still a mystery? An overview","volume":"2","author":"Naidu","year":"2003","journal-title":"Nutr J"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib3","first-page":"193","article-title":"Vitamin C supplementation in the critically ill patient","volume":"18","author":"Berger","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13054-018-1996-y","article-title":"Making sense of early high-dose intravenous vitamin C in ischemia\/reperfusion injury","volume":"22","author":"Spoelstra-de Man","year":"2018","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.gendis.2025.101742_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/01.CIR.0000050626.25057.51","article-title":"Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression","volume":"107","author":"Salonen","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s13054-019-2693-1","article-title":"Effect of high-dose vitamin C therapy on severe burn patients: a nationwide cohort study","volume":"23","author":"Nakajima","year":"2019","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.gendis.2025.101742_bib7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.21037\/apm-22-225","article-title":"Clinical efficacy and safety of vitamin C in the treatment of septic shock patients: systematic review and meta-analysis","volume":"11","author":"Cai","year":"2022","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.gendis.2025.101742_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6733465","article-title":"IV vitamin C in sepsis: a latest systematic review and meta-analysis","volume":"2023","author":"Wen","year":"2023","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13613-020-00792-3","article-title":"Pilot trial of high-dose vitamin C in critically ill COVID-19 patients","volume":"11","author":"Zhang","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.gendis.2025.101742_bib10","first-page":"166","article-title":"A collagen disease, secondary to a nutritional deficiency","volume":"76","author":"Cancer","year":"1959","journal-title":"Arch Pediatr"},{"issue":"4","key":"10.1016\/j.gendis.2025.101742_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0009-2797(74)90019-2","article-title":"The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer","volume":"9","author":"Cameron","year":"1974","journal-title":"Chem Biol Interact"},{"issue":"10","key":"10.1016\/j.gendis.2025.101742_bib12","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1073\/pnas.73.10.3685","article-title":"Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer","volume":"73","author":"Cameron","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.gendis.2025.101742_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJM197909273011303","article-title":"Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer","volume":"301","author":"Creagan","year":"1979","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198501173120301","article-title":"High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison","volume":"312","author":"Moertel","year":"1985","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.gendis.2025.101742_bib15","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.93.8.3704","article-title":"Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance","volume":"93","author":"Levine","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.gendis.2025.101742_bib16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1172\/JCI39191","article-title":"Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice","volume":"120","author":"Corpe","year":"2010","journal-title":"J Clin Investig"},{"issue":"7","key":"10.1016\/j.gendis.2025.101742_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-140-7-200404060-00010","article-title":"Vitamin C pharmacokinetics: implications for oral and intravenous use","volume":"140","author":"Padayatty","year":"2004","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3945\/an.110.000109","article-title":"A concentration-function approach yields pharmacology and therapeutic discoveries","volume":"2","author":"Levine","year":"2011","journal-title":"Adv Nutr"},{"key":"10.1016\/j.gendis.2025.101742_bib19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3389\/fonc.2020.00976","article-title":"Vitamin C promotes apoptosis and cell cycle arrest in oral squamous cell carcinoma","volume":"10","author":"Zhou","year":"2020","journal-title":"Front Oncol"},{"issue":"38","key":"10.1016\/j.gendis.2025.101742_bib20","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-017-0044-8","article-title":"Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2","volume":"2","author":"Lv","year":"2018","journal-title":"npj Precis Oncol"},{"issue":"32","key":"10.1016\/j.gendis.2025.101742_bib22","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1073\/pnas.0804226105","article-title":"Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice","volume":"105","author":"Chen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1479-5876-7-70","article-title":"High dose concentration administration of ascorbic acid inhibits tumor growth in BALB\/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis","volume":"7","author":"Yeom","year":"2009","journal-title":"J Transl Med"},{"issue":"7","key":"10.1016\/j.gendis.2025.101742_bib24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/01635581.2012.713539","article-title":"Cytotoxicity of ascorbic acid in a human colorectal adenocarcinoma cell line (WiDr): in vitro and in vivo studies","volume":"64","author":"Mamede","year":"2012","journal-title":"Nutr Cancer"},{"issue":"7","key":"10.1016\/j.gendis.2025.101742_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011414","article-title":"Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects","volume":"5","author":"Padayatty","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1534735415622010","article-title":"Effects of high doses of vitamin C on cancer patients in Singapore: nine cases","volume":"15","author":"Raymond","year":"2016","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00280-013-2179-9","article-title":"Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer","volume":"72","author":"Stephenson","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.21037\/tau.2017.04.42","article-title":"Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial","volume":"6","author":"Nielsen","year":"2017","journal-title":"Transl Androl Urol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101742_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/CAD.0000000000000603","article-title":"Treatment of pancreatic cancer with intravenous vitamin C: a case report","volume":"29","author":"Drisko","year":"2018","journal-title":"Anti Cancer Drugs"},{"issue":"222","key":"10.1016\/j.gendis.2025.101742_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3892\/ol.2017.6109","article-title":"The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cells","volume":"14","author":"Lee","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.gendis.2025.101742_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101864","article-title":"Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy","volume":"42","author":"Petronek","year":"2021","journal-title":"Redox Biol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101742_bib33","first-page":"983","article-title":"Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-\/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany","volume":"25","author":"Vollbracht","year":"2011","journal-title":"In Vivo (Athens)"},{"key":"10.1016\/j.gendis.2025.101742_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fonc.2014.00283","article-title":"The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life","volume":"4","author":"Carr","year":"2014","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajcn\/nqy223","article-title":"Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy","volume":"109","author":"Jung","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.gendis.2025.101742_bib36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3390\/nu12051501","article-title":"Two faces of vitamin C-antioxidative and pro-oxidative agent","volume":"12","author":"Ka\u017amierczak-Bara\u0144ska","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.gendis.2025.101742_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114695","article-title":"Cell signaling pathways based on vitamin C and their application in cancer therapy","volume":"162","author":"Fan","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"10.1016\/j.gendis.2025.101742_bib38","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.7150\/thno.35219","article-title":"Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK\/ERK and PI3K\/AKT pathways via distinct mechanisms","volume":"9","author":"Su","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.gendis.2025.101742_bib39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fonc.2020.00476","article-title":"Altered iron metabolism and impact in cancer biology, metastasis, and immunology","volume":"10","author":"Brown","year":"2020","journal-title":"Front Oncol"},{"issue":"43","key":"10.1016\/j.gendis.2025.101742_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001127","article-title":"Ferroportin and iron regulation in breast cancer progression and prognosis","volume":"2","author":"Pinnix","year":"2010","journal-title":"Sci Transl Med"},{"issue":"16","key":"10.1016\/j.gendis.2025.101742_bib41","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1158\/0008-5472.CAN-13-0470","article-title":"Manganoporphyrins increase ascorbate-induced cytotoxicity by enhancing H2O2 generation","volume":"73","author":"Rawal","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.gendis.2025.101742_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.600715","article-title":"Vitamin C administration by intravenous infusion increases tumor ascorbate content in patients with colon cancer: a clinical intervention study","volume":"10","author":"Dachs","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.gendis.2025.101742_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ebiom.2017.02.011","article-title":"Multiple myeloma tumor cells are selectively killed by pharmacologically-dosed ascorbic acid","volume":"18","author":"Xia","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.gendis.2025.101742_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1472-6882-12-61","article-title":"Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress","volume":"12","author":"Klingelhoeffer","year":"2012","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.gendis.2025.101742_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.03.039","article-title":"SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts","volume":"398","author":"Wang","year":"2017","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.gendis.2025.101742_bib46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0891-5849(95)02130-2","article-title":"Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate","volume":"20","author":"May","year":"1996","journal-title":"Free Radic Biol Med"},{"issue":"6266","key":"10.1016\/j.gendis.2025.101742_bib47","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C selectively killsKRASandBRAFmutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29386-7","article-title":"Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression","volume":"8","author":"Cho","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.gendis.2025.101742_bib49","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/onc.2012.176","article-title":"SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment","volume":"32","author":"Hong","year":"2013","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.gendis.2025.101742_bib50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev"},{"issue":"6","key":"10.1016\/j.gendis.2025.101742_bib51","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.gendis.2025.101742_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.65","article-title":"Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells","volume":"7","author":"Shenoy","year":"2017","journal-title":"Blood Cancer J"},{"issue":"7673","key":"10.1016\/j.gendis.2025.101742_bib53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nature23876","article-title":"Ascorbate regulates haematopoietic stem cell function and leukaemogenesis","volume":"549","author":"Agathocleous","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13148-015-0087-z","article-title":"Epigenetic reprogramming of melanoma cells by vitamin C treatment","volume":"7","author":"Gustafson","year":"2015","journal-title":"Clin Epigenet"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13148-018-0527-7","article-title":"Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer","volume":"10","author":"Peng","year":"2018","journal-title":"Clin Epigenet"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ncrna.2016.09.001","article-title":"Non-coding RNA\/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins","volume":"1","author":"Biersack","year":"2016","journal-title":"Non Coding RNA Res"},{"issue":"5","key":"10.1016\/j.gendis.2025.101742_bib57","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/carcin\/bgt026","article-title":"microRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis","volume":"34","author":"Singh","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2025.101742_bib58","first-page":"39","article-title":"microRNA-153 regulates NRF2 expression and is associated with breast carcinogenesis","volume":"62","author":"Wang","year":"2016","journal-title":"Clin Lab"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13046-019-1044-z","article-title":"Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer","volume":"38","author":"Fan","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib60","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1073\/pnas.1908158117","article-title":"High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model","volume":"117","author":"Luchtel","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2017.10.005","article-title":"Advances in hypoxia-inducible factor biology","volume":"27","author":"Choudhry","year":"2018","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.gendis.2025.101742_bib62","first-page":"1764","article-title":"Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells","volume":"63","author":"Knowles","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12885-019-5503-x","article-title":"Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels","volume":"19","author":"Campbell","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gendis.2025.101742_bib64","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1186\/s12885-015-1878-5","article-title":"Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells","volume":"15","author":"Miles","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gendis.2025.101742_bib65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fonc.2014.00010","article-title":"Increased tumor ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible factor-1 activation in human colorectal cancer","volume":"4","author":"Kuiper","year":"2014","journal-title":"Front Oncol"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2025.101742_bib66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10585-018-9876-z","article-title":"Pharmacologic ascorbate (P-AscH\u2212) suppresses hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) in pancreatic adenocarcinoma","volume":"35","author":"Wilkes","year":"2018","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-017-0388-y","article-title":"Expression of hypoxia inducible factor 1\u03b1 and 2\u03b1 and its association with vitamin C level in thyroid lesions","volume":"24","author":"J\u00f3\u017awiak","year":"2017","journal-title":"J Biomed Sci"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib68","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cam4.349","article-title":"Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo\u2212\/\u2212 mice","volume":"4","author":"Campbell","year":"2015","journal-title":"Cancer Med"},{"issue":"14","key":"10.1016\/j.gendis.2025.101742_bib69","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1158\/0008-5472.CAN-10-0263","article-title":"Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer","volume":"70","author":"Kuiper","year":"2010","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.gendis.2025.101742_bib70","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1074\/jbc.M113.538157","article-title":"The hypoxia-inducible factor renders cancer cells more sensitive to vitamin C-induced toxicity","volume":"289","author":"Tian","year":"2014","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2025.101742_bib71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 Years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"issue":"7092","key":"10.1016\/j.gendis.2025.101742_bib72","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2025.101742_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112553","article-title":"The potential role of vitamin C in empowering cancer immunotherapy","volume":"146","author":"Bedhiafi","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"43","key":"10.1016\/j.gendis.2025.101742_bib74","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1021\/bi0263210","article-title":"Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation","volume":"41","author":"C\u00e1rcamo","year":"2002","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.gendis.2025.101742_bib75","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.4049\/jimmunol.165.12.7180","article-title":"Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase","volume":"165","author":"Bowie","year":"2000","journal-title":"J Immunol"},{"issue":"19","key":"10.1016\/j.gendis.2025.101742_bib76","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1093\/nar\/gkac941","article-title":"Vitamin C enhances NF-\u03baB-driven epigenomic reprogramming and boosts the immunogenic properties of dendritic cells","volume":"50","author":"Morante-Palacios","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gendis.2025.101742_bib77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.freeradbiomed.2022.01.007","article-title":"Prooxidative inhibition against NF-\u03baB-mediated inflammation by pharmacological vitamin C","volume":"180","author":"Du","year":"2022","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/antiox7030041","article-title":"Influence of vitamin C on lymphocytes: an overview","volume":"7","author":"van Gorkom","year":"2018","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.gendis.2025.101742_bib79","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST20180169","article-title":"Vitamin C and immune cell function in inflammation and cancer","volume":"46","author":"Ang","year":"2018","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.gendis.2025.101742_bib80","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73754","article-title":"Epigenetic remodeling by vitamin C potentiates plasma cell differentiation","volume":"11","author":"Chen","year":"2022","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib81","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cellimm.2010.10.005","article-title":"Vitamin C-treated murine bone marrow-derived dendritic cells preferentially drive na\u00efve T cells into Th1 cells by increased IL-12 secretions","volume":"266","author":"Jeong","year":"2011","journal-title":"Cell Immunol"},{"issue":"532","key":"10.1016\/j.gendis.2025.101742_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8707","article-title":"High-dose vitamin C enhances cancer immunotherapy","volume":"12","author":"Magr\u00ec","year":"2020","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.gendis.2025.101742_bib83","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1172\/JCI129317","article-title":"Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy","volume":"129","author":"Xu","year":"2019","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.gendis.2025.101742_bib84","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41423-019-0247-8","article-title":"Vitamin C promotes the proliferation and effector functions of human \u03b3\u03b4 T cells","volume":"17","author":"Kouakanou","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"10.1016\/j.gendis.2025.101742_bib85","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jcyt.2015.01.004","article-title":"Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy","volume":"17","author":"Huijskens","year":"2015","journal-title":"Cytotherapy"},{"issue":"4\u20135","key":"10.1016\/j.gendis.2025.101742_bib86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2004.02.004","article-title":"Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes","volume":"27","author":"H\u00e4rtel","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.gendis.2025.101742_bib87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12659\/MSM.895368","article-title":"Modulation of cytokines in cancer patients by intravenous ascorbate therapy","volume":"22","author":"Mikirova","year":"2016","journal-title":"Med Sci Monit"},{"issue":"12","key":"10.1016\/j.gendis.2025.101742_bib88","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.2019004158","article-title":"TET family dioxygenases and the TET activator vitamin C in immune responses and cancer","volume":"136","author":"Yue","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1479-5876-10-189","article-title":"Effect of high-dose intravenous vitamin C on inflammation in cancer patients","volume":"10","author":"Mikirova","year":"2012","journal-title":"J Transl Med"},{"issue":"6","key":"10.1016\/j.gendis.2025.101742_bib90","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/odi.12446","article-title":"Vitamin C: the known and the unknown and goldilocks","volume":"22","author":"Padayatty","year":"2016","journal-title":"Oral Dis"},{"issue":"10","key":"10.1016\/j.gendis.2025.101742_bib91","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12032-023-02155-x","article-title":"Vitamin C inhibits the growth of colorectal cancer cell HCT116 and reverses the glucose-induced oncogenic effect by downregulating the Warburg effect","volume":"40","author":"Yu","year":"2023","journal-title":"Med Oncol"},{"key":"10.1016\/j.gendis.2025.101742_bib92","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.freeradbiomed.2024.01.019","article-title":"Redox modulation of oxidatively-induced DNA damage by ascorbate enhances both in vitro and ex-vivo DNA damage formation and cell death in melanoma cells","volume":"213","author":"Najeeb","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.gendis.2025.101742_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103288","article-title":"Redox-active vitamin C suppresses human osteosarcoma growth by triggering intracellular ROS-iron-calcium signaling crosstalk and mitochondrial dysfunction","volume":"75","author":"Vaishampayan","year":"2024","journal-title":"Redox Biol"},{"issue":"Pt 1","key":"10.1016\/j.gendis.2025.101742_bib94","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.freeradbiomed.2023.10.391","article-title":"SERPINE1 and SERPINB7 as potential biomarkers for intravenous vitamin C treatment in non-small-cell lung cancer","volume":"209","author":"Ou","year":"2023","journal-title":"Free Radic Biol Med"},{"issue":"30","key":"10.1016\/j.gendis.2025.101742_bib95","doi-asserted-by":"crossref","first-page":"47954","DOI":"10.18632\/oncotarget.10087","article-title":"Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer","volume":"7","author":"Aguilera","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.gendis.2025.101742_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111321","article-title":"High dose Vitamin C inhibits PD-L1 by ROS-pSTAT3 signal pathway and enhances T cell function in TNBC","volume":"126","author":"Zhao","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib97","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-023-43743-9","article-title":"TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer","volume":"15","author":"Lv","year":"2024","journal-title":"Nat Commun"},{"issue":"22","key":"10.1016\/j.gendis.2025.101742_bib98","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.175098","article-title":"TET2 promotes tumor antigen presentation and T cell IFN-\u03b3, which is enhanced by vitamin C","volume":"9","author":"Cheng","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.gendis.2025.101742_bib99","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.freeradbiomed.2024.07.008","article-title":"Pharmacologic ascorbate induces transient hypoxia sensitizing pancreatic ductal adenocarcinoma to a hypoxia activated prodrug","volume":"222","author":"Kishimoto","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.gendis.2025.101742_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113321","article-title":"Vitamin C-induced competitive binding of HIF-1\u03b1 and p53 to ubiquitin E3 ligase CBL contributes to anti-breast cancer progression through p53 deacetylation","volume":"168","author":"Xiong","year":"2022","journal-title":"Food Chem Toxicol"},{"issue":"26","key":"10.1016\/j.gendis.2025.101742_bib101","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.7150\/thno.35378","article-title":"Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH\u2212)","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.gendis.2025.101742_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167358","article-title":"High-dose vitamin C attenuates radiation-induced pulmonary fibrosis by targeting S100A8 and S100A9","volume":"1870","author":"Ma","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"10.1016\/j.gendis.2025.101742_bib103","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1667\/RR14978.1","article-title":"Pharmacological ascorbate as an adjuvant for enhancing radiation-chemotherapy responses in gastric adenocarcinoma","volume":"189","author":"O'Leary","year":"2018","journal-title":"Radiat Res"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib104","doi-asserted-by":"crossref","first-page":"119","DOI":"10.29252\/ibj.24.2.119","article-title":"Synergistic effect of vitamin C with cisplatin for inhibiting proliferation of gastric cancer cells","volume":"24","author":"Ghavami","year":"2020","journal-title":"Iran Biomed J"},{"issue":"11","key":"10.1016\/j.gendis.2025.101742_bib105","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.freeradbiomed.2011.03.007","article-title":"Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer","volume":"50","author":"Espey","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"10.1016\/j.gendis.2025.101742_bib106","first-page":"2212","article-title":"Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest","volume":"18","author":"Cenigaonandia-Campillo","year":"2024","journal-title":"Mol Oncol"},{"key":"10.1016\/j.gendis.2025.101742_bib107","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ygyno.2024.03.021","article-title":"High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines","volume":"183","author":"Shen","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gendis.2025.101742_bib108","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.freeradbiomed.2016.03.009","article-title":"L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells","volume":"95","author":"Jung","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.gendis.2025.101742_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116798","article-title":"Vitamin C enhances the sensitivity of osteosarcoma to arsenic trioxide via inhibiting aerobic glycolysis","volume":"482","author":"Liu","year":"2024","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib110","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/bjh.19680","article-title":"Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C","volume":"205","author":"Hei","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.gendis.2025.101742_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103375","article-title":"A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer","volume":"77","author":"Bodeker","year":"2024","journal-title":"Redox Biol"},{"issue":"15","key":"10.1016\/j.gendis.2025.101742_bib112","article-title":"Broad safety impact of high-dose ascorbic acid and induction chemotherapy for high-risk pancreatic cancer","volume":"35","author":"Howard","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib113","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","article-title":"Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial","volume":"71","author":"Welsh","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"issue":"24","key":"10.1016\/j.gendis.2025.101742_bib114","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1158\/0008-5472.CAN-18-1680","article-title":"Pharmacologic ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer","volume":"78","author":"Alexander","year":"2018","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.gendis.2025.101742_bib115","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/1078-0432.CCR-19-0594","article-title":"First-in-human phase I clinical trial of pharmacologic ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma","volume":"25","author":"Allen","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17568-8","article-title":"High dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: mechanisms and a phase I\/IIa study","volume":"7","author":"Polireddy","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.gendis.2025.101742_bib117","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0022-5347(17)37521-3","article-title":"Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis","volume":"147","author":"Urivetzky","year":"1992","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib118","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.metabol.2008.09.023","article-title":"Oxalic acid excretion after intravenous ascorbic acid administration","volume":"58","author":"Robitaille","year":"2009","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.gendis.2025.101742_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120228","article-title":"High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial","volume":"10","author":"Hoffer","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029794","article-title":"Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer","volume":"7","author":"Monti","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib121","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/1078-0432.CCR-22-3952","article-title":"Magnetic resonance imaging of iron metabolism with T2\u2217 mapping predicts an enhanced clinical response to pharmacologic ascorbate in patients with GBM","volume":"30","author":"Petronek","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gendis.2025.101742_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102318","article-title":"Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer","volume":"53","author":"Furqan","year":"2022","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib123","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1159\/000539979","article-title":"Pembrolizumab plus pharmacologic ascorbate in the treatment of leiomyosarcoma","volume":"17","author":"Rieth","year":"2024","journal-title":"Case Rep Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib124","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12885-019-5696-z","article-title":"Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"issue":"19","key":"10.1016\/j.gendis.2025.101742_bib125","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1158\/1078-0432.CCR-22-0655","article-title":"A randomized, open-label, multicenter, phase 3 study of high-dose vitamin C plus FOLFOX \u00b1 bevacizumab versus FOLFOX \u00b1 bevacizumab in unresectable untreated metastatic colorectal cancer (VITALITY study)","volume":"28","author":"Wang","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gendis.2025.101742_bib126","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejps.2017.08.011","article-title":"The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer","volume":"109","author":"Ou","year":"2017","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.gendis.2025.101742_bib127","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jare.2020.03.004","article-title":"A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer","volume":"24","author":"Ou","year":"2020","journal-title":"J Adv Res"},{"issue":"9","key":"10.1016\/j.gendis.2025.101742_bib128","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s40262-022-01142-1","article-title":"Pharmacokinetic evaluation of intravenous vitamin C: a classic pharmacokinetic study","volume":"61","author":"Chen","year":"2022","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib129","first-page":"115","article-title":"Intravenous vitamin C as a chemotherapy agent: a report on clinical cases","volume":"23","author":"Riordan","year":"2004","journal-title":"Puert Rico Health Sci J"},{"key":"10.1016\/j.gendis.2025.101742_bib130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.foodchem.2016.10.012","article-title":"Factors that impact the stability of vitamin C at intermediate temperatures in a food matrix","volume":"220","author":"Herbig","year":"2017","journal-title":"Food Chem"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib131","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1021\/acsami.9b16209","article-title":"Self-assembled gemcitabine prodrug nanoparticles show enhanced efficacy against patient-derived pancreatic ductal adenocarcinoma","volume":"12","author":"Wu","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib132","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12951-021-00910-8","article-title":"Ecotoxicity evaluation of polymeric nanoparticles loaded with ascorbic acid for fish nutrition in aquaculture","volume":"19","author":"Luis","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.gendis.2025.101742_bib133","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.crfs.2021.03.010","article-title":"Encapsulation and controlled release of vitamin C in modified cellulose nanocrystal\/chitosan nanocapsules","volume":"4","author":"Baek","year":"2021","journal-title":"Curr Res Food Sci"},{"issue":"2","key":"10.1016\/j.gendis.2025.101742_bib134","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10068-018-0493-z","article-title":"New formulation of vitamin C encapsulation by nanoliposomes: production and evaluation of particle size, stability and control release","volume":"28","author":"Amiri","year":"2018","journal-title":"Food Sci Biotechnol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101742_bib135","doi-asserted-by":"crossref","first-page":"17389","DOI":"10.1021\/acsnano.2c08446","article-title":"Polarization of tumor-associated macrophages promoted by vitamin C-loaded liposomes for cancer immunotherapy","volume":"16","author":"Ma","year":"2022","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.gendis.2025.101742_bib136","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.7150\/thno.33783","article-title":"Ascorbic acid induced HepG2 cells' apoptosis via intracellular reductive stress","volume":"9","author":"Gao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.gendis.2025.101742_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117292","article-title":"Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: in silico and in vitro studies","volume":"239","author":"Amiri","year":"2023","journal-title":"Environ Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib138","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/08982104.2019.1630642","article-title":"New oral liposomal vitamin C formulation: properties and bioavailability","volume":"30","author":"\u0141ukawski","year":"2020","journal-title":"J Liposome Res"},{"issue":"8","key":"10.1016\/j.gendis.2025.101742_bib139","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1021\/acsomega.0c05963","article-title":"Fiber-reinforced-phospholipid vehicle-based delivery of l-ascorbic acid: development, characterization, ADMET profiling, and efficacy by a randomized, single-dose, crossover oral bioavailability study","volume":"6","author":"Jacob","year":"2021","journal-title":"ACS Omega"},{"issue":"13","key":"10.1016\/j.gendis.2025.101742_bib140","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.3390\/nu15133073","article-title":"Pharmacokinetic analyses of liposomal and non-liposomal multivitamin\/mineral formulations","volume":"15","author":"Ko","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib141","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13590840802305423","article-title":"Pharmacokinetics of oral vitamin C","volume":"17","author":"Hickey","year":"2008","journal-title":"J Nutr Environ Med"},{"key":"10.1016\/j.gendis.2025.101742_bib142","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/NMI.S39764","article-title":"Liposomal-encapsulated ascorbic acid: influence on vitamin C bioavailability and capacity to protect against ischemia-reperfusion injury","volume":"9","author":"Davis","year":"2016","journal-title":"Nutr Metab Insights"},{"issue":"8","key":"10.1016\/j.gendis.2025.101742_bib143","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1007\/s00394-024-03487-8","article-title":"Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial","volume":"63","author":"Purpura","year":"2024","journal-title":"Eur J Nutr"},{"issue":"7","key":"10.1016\/j.gendis.2025.101742_bib144","first-page":"29","article-title":"Effect of liposomal vitamin C on immune function in children aged 4-12 years","volume":"73","author":"Dound","year":"2020"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib145","article-title":"Role of high dose oral liposomal vitamin-C in reducing mortality in patients with COVID-19","volume":"10","author":"Vishnuram","year":"2021","journal-title":"IJBAMR"},{"issue":"23","key":"10.1016\/j.gendis.2025.101742_bib146","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.3390\/nu14234984","article-title":"Effects of l-arginine plus vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: a single-blind randomized controlled trial","volume":"14","author":"Tosato","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib147","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/10717544.2022.2036872","article-title":"Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in Melasma patients","volume":"29","author":"Kandil","year":"2022","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib148","article-title":"Encapsulation of vitamin C by a double-layer zein\/chitosan structure with improved stability and controlled release","volume":"2","author":"Dong","year":"2016","journal-title":"Int Nanomed Nanosurg"},{"issue":"7","key":"10.1016\/j.gendis.2025.101742_bib149","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1476-5381.2011.01350.x","article-title":"The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C","volume":"164","author":"May","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"14","key":"10.1016\/j.gendis.2025.101742_bib150","article-title":"Bridging smart nanosystems with clinically relevant models and advanced imaging for precision drug delivery","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"10.1016\/j.gendis.2025.101742_bib151","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1039\/C6CS00592F","article-title":"Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment","volume":"46","author":"Dai","year":"2017","journal-title":"Chem Soc Rev"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib152","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2020.8166","article-title":"Transport of vitamin C in cancer","volume":"35","author":"Mu\u00f1oz-Montesino","year":"2021","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.gendis.2025.101742_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.675780","article-title":"Epigenetic regulation of genomic stability by vitamin C","volume":"12","author":"Brabson","year":"2021","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib154","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s42003-020-01220-9","article-title":"Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia","volume":"3","author":"Guan","year":"2020","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101742_bib155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/leu.2017.171","article-title":"Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia","volume":"32","author":"Mingay","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.gendis.2025.101742_bib156","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-019-0242-4","article-title":"Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1","volume":"9","author":"Das","year":"2019","journal-title":"Blood Cancer J"},{"issue":"11","key":"10.1016\/j.gendis.2025.101742_bib157","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41416-023-02452-2","article-title":"Vitamin C intake and colorectal cancer survival according to KRAS and BRAF mutation: a prospective study in two US cohorts","volume":"129","author":"Shi","year":"2023","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2025.101742_bib158","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/cancers12030685","article-title":"Vitamin C restricts the emergence of acquired resistance to EGFR-targeted therapies in colorectal cancer","volume":"12","author":"Lorenzato","year":"2020","journal-title":"Cancers"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225002314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225002314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T17:48:20Z","timestamp":1768758500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225002314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":158,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2352304225002314"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101742","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose vitamin C: A promising anti-tumor agent, insight from mechanisms, clinical research, and challenges","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101742"}}